Gilead Sciences to Release Fourth Quarter & Full Year 2022 Financial Results on Thursday, February 2, 2023

Rhea-AI Summary

Gilead Sciences, Inc. (NASDAQ: GILD) is set to release its fourth quarter and full year 2022 financial results along with the full year 2023 financial guidance on February 2 after market close. A management webcast will follow at 4:30 p.m. Eastern Time to discuss these results and provide a business update. Gilead, a biopharmaceutical company headquartered in Foster City, California, has been dedicated to creating innovative medicines for over 30 years, focusing on life-threatening diseases such as HIV, viral hepatitis, and cancer. The live webcast will be accessible on Gilead's Investor Relations website.

Positive

• Upcoming release of fourth quarter and full year 2022 financial results may highlight growth metrics.
• Management webcast provides an opportunity for shareholders to gain insights into the company's strategy.

Negative

• None.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2022 financial results and full year 2023 financial guidance will be released on Thursday, February 2 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2022 financial results and provide a business update.

A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005621/en/

Jacquie Ross, CFA – Investors

investor_relations@gilead.com

Source: Gilead Sciences, Inc.

FAQ

When will Gilead Sciences announce its fourth quarter 2022 earnings?

Gilead Sciences will announce its fourth quarter earnings on February 2, 2023.

What time is the Gilead Sciences earnings webcast scheduled?

The earnings webcast is scheduled for 4:30 p.m. Eastern Time on February 2, 2023.

Where can I access Gilead Sciences' financial results?

The financial results can be accessed on Gilead's Investor Relations website after the announcement.

What is the focus of Gilead Sciences' business?

Gilead focuses on developing innovative medicines for life-threatening diseases, including HIV, viral hepatitis, and cancer.

What is the stock symbol for Gilead Sciences?

Gilead Sciences' stock symbol is GILD.